Benefits and safety of major medicines in HIV patients.
Not Applicable
- Conditions
- Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Minimum 1000 patients for retrospective and prospective studies with confirmed and documented HIV1 infection on Dolutegravir, Lamivudine and Tenofovir Alafenamide
Exclusion Criteria
Patients on 2nd, 3rd, other regimens and patients not giving consent to the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method